Article

Coronary artery calcification common with lupus

The prevalence and extent of vascular calcification over the thoracic aorta and coronary and carotid arteries are greater in patients with systemic lupus erythematosus (SLE) than in healthy persons. Because the process of atherosclerosis related to SLE disease activity is diffuse and widespread rather than limited to the coronary arteries, coronary calcification used alone as a marker for atherosclerosis may not disclose the association.

The prevalence and extent of vascular calcification over the thoracic aorta and coronary and carotid arteries are greater in patients with systemic lupus erythematosus (SLE) than in healthy persons. Because the process of atherosclerosis related to SLE disease activity is diffuse and widespread rather than limited to the coronary arteries, coronary calcification used alone as a marker for atherosclerosis may not disclose the association.

Yiu and associates used multidetector CT to compare the prevalence and pattern of subclinical calcified plaque in persons with SLE versus controls. None of the 100 study participants had a history of cardiovascular disease.

Patients with SLE had the highest mean coronary, carotid, aortic, and total calcification scores (CS). They were significantly more likely than controls to have a CS higher than 0 in coronary and carotid arteries, the aorta, and any vascular bed. Calcification was most pronounced in the coronary arteries, followed by the carotid and aortic arteries. Only the patients with SLE had simultaneous calcification over the thoracic aorta and coronary and carotid arteries.

The authors noted that their findings have important implications for the understanding of the premature atherogenesis process and provide a cornerstone for future studies.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.